drugset
drugset / Trial / NCT03951116

Study of FCN-437c in Patients With Advanced Solid Tumors

NCT03951116 ↗

Phase 1 Completed 22 enrolled Fochon Pharmaceuticals, Ltd.
NaSingle-groupOpen-labelTreatment

Summary

This research study is studying a drug called FCN-437c as a possible treatment for patients with advanced unresectable/metastatic solid tumors.

Timeline

Start
2019-06-25
Primary completion
2021-12-08
Completion
2021-12-08

Drugs

EvaluationDrugModalityDoseRoute
Subject FCN-437 Unknown — Oral

Indications

cancer